Effects of 1,25(OH)(2)D-3 in experimental mesangial proliferative nephritis in rats

Citation
V. Panichi et al., Effects of 1,25(OH)(2)D-3 in experimental mesangial proliferative nephritis in rats, KIDNEY INT, 60(1), 2001, pp. 87-95
Citations number
31
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
KIDNEY INTERNATIONAL
ISSN journal
00852538 → ACNP
Volume
60
Issue
1
Year of publication
2001
Pages
87 - 95
Database
ISI
SICI code
0085-2538(200107)60:1<87:EO1IEM>2.0.ZU;2-B
Abstract
Background. 1,25-Dihydroxyvitamin D-3 [1,25(OH)(2)D-3], the active form of vitamin D,, is a potent immunomodulatory agent on several cell types such a s monocytes and mesangial cells. Recruitment of inflammatory cells, as well as stimulation of resident cells and mesangial matrix accumulation are key features of various experimental and human glomerular diseases. Here we sh ow that 1,25(OH)(2)D-3 attenuates the morphologic and functional alteration s in anti-Thy-1,1. nephritis. an experimental model of mesangial proliferat ive glomerulonephritis. Methods. The anti-Thy-1,1 group (group I) comprised 24 rats that at day 0 r eceived 0.5 mt of saline containing 400 mug of monoclonal antibodies (mAb) anti-Thy-1,1 IgG. The antiThy-1,1 treated with 1.25(OH)(2)D-3 group (group II) were 24 rats given 1,25(OH)(2)D-3 at the dose of 25 ng/100 g body wt/da y. From day -3 to day 14. At day 0, the rats received 400 mug of anti-Thy-1 ,1 monoclonal IgG. The control group (group III) comprised 12 rats injected with vehicle alone; the control group treated with 1,25(OH)(2)D-3 (group I V)-12 rats were given 1,25(OH)(2)D-3 as in group II without mAb administrat ion. Proteinuria and urinary interleukin-h excretion were measured daily. B lood urea nitrogen and creatinine, creatinine clearance. calcium, and phosp hate were measured at days 0, 4, 7, and 14. In addition to conventional per iodic acid-Schiff staining. binding of anti-Thy-1,1 IgG and C3b complement fraction. His48- and ED1-positive cells were studied by immunofluorescence. Mesangial proliferation was studied by the proliferating cell nuclear anti gen (PCNA) technique. Apoptosis was evaluated by the TUNEL assay. Results. The anti-Thy-1,1 treated with 1.25(OH),D, group versus the anti-Th y-1,1 alone group showed a significant reduction in urinary protein (at day 7, 424 +/- 228 vs. 66 +/- 30 mg/mg urinary creatinine. P = 0.02) and inter leukin-h excretion (at day 3, 537 +/- 360 pg/mL vs. 110 +/- 34 pg/mg urinar y creatinine. P = 0.015), reduced glomerular diameters (at day 7. 283 +/- 3 8 vs. 261 +/- 48 mum. P < 0.01). decreased neutrophil (at day 4, 20 +/- 12 His48-positive cells/glomerulus vs. 3.7 +/- 1.3 His48-positive cells/glomer ulus, P < 0.001). and monocyte accumulation (day 7, 4.9 +/- 2.9 ED1-positiv e cells/glomerulus vs. 2.8 +/- 2.9 ED1-positive cells/glomerulus, P < 0.05) , and attenuated glomerular cells proliferation (day 7. 13 +/- 3.2 PCNA-pos itive cells/glomerulus vs. 9.4 +/- 3 PCNA-positive cells/glomerulus, P < 0. 01). Apoptosis showed a biphasic behavior with an early peak at day 4 in th e anti-Thy-1,1 group (2.3 +/- 2.2 TUNEL positive ceils/glom) related to cel lular lysis and a late peak at day 14 related to the recovery phase. Conclusions. 1,25(OH)(2)D-3 can reduce glomerular hypercellularity, inflamm atory infiltration in anti-Thy-1,1 nephritis, preserving the apoptotic resp onse of the reparative phase.